Physician profile
James F Mitchell
NPI 1598705485
$1,147.47
in general payments reported to CMS, 2019-2025
9 companies · $168 in 2025
The $168 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $220 · 2020: $21.69 · 2021: $60.91 · 2022: $280 · 2023: $200 · 2024: $197 · 2025: $168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $565.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $564.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $849.99 | 2019-2025 | Oasis, Grafix Pl, Grafix |
| Misonix INC | $82.52 | 2019-2021 | |
| Integra Lifesciences Corporation | $64.98 | 2019-2020 | |
| Tei Medical INC. | $35.29 | 2019 | |
| Bioventus LLC | $28.80 | 2022 | |
| Organogenesis INC. | $25.05 | 2019 | |
| Next Science LLC | $23.97 | 2023 | Xperience, Blastx, Surgx |
| Kerecis Limited | $21.92 | 2021 | |
| Apria Healthcare LLC | $14.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.